Endothelial dysfunction is a predictor of diseases of the cardiovascular system, as well as diseases of other organs and systems, including diabetes, its development is a negative prognostic sign. When combined coronary heart disease with diabetes, endothelial dysfunction worsens the course of both diseases, leading to serious complications. This necessitates the inclusion of a standard regimen of treatment that are able to prevent or reduce the expression of endothelial dysfunction. Many years of experience of using by physicians and clinical trial results proving efficacy of L-arginine as a correction release of nitric oxide, decrease of oxidative stress and endothelial cells dysfunction